Results 1 to 10 of about 7,957 (160)

Synthesis and Anti-Tumor Evaluation of Carboranyl BMS-202 Analogues—A Case of Carborane Not as Phenyl Ring Mimetic [PDF]

open access: yesMolecules
Carborane is considered a three-dimensional mimetic of phenyl rings in medicinal chemistry. BMS-202 is a potent PD-L1 inhibitor that can block the PD-L1/PD-1 interaction and restore the immune response to cancer cells.
Changxian Yuan   +14 more
doaj   +2 more sources

Crystal structure of 1-butyl-2,3-dimethylimidazolium dicarba-7,8-nido-undecaborate [PDF]

open access: yesActa Crystallographica Section E: Crystallographic Communications, 2015
In the title molecular salt, C9H17N2+·C2H12B9−, the carborane cage has a bridging B—H—B bond on the open B3C2 face. The butyl side chain of the cation adopts an extended conformation [C—C—C—C = 179.6 (1)°].
M. J. Klemes   +3 more
doaj   +3 more sources

Charge-Compensated Derivatives of Nido-Carborane

open access: yesInorganics, 2023
This review summarizes data on the main types of charge-compensated nido-carborane derivatives. Compared with organic analogs, onium derivatives of nido-carborane have increased stability due to the stabilizing electron-donor action of the boron cage ...
Marina Yu Stogniy   +2 more
exaly   +3 more sources

Enhancement of Aggregation-Induced Emission by Introducing Multiple o-Carborane Substitutions into Triphenylamine

open access: yesMolecules, 2017
The enhancement of aggregation-induced emission (AIE) is presented on the basis of the strategy for improving solid-state luminescence by employing multiple o-carborane substituents.
Kyoya Uemura   +2 more
exaly   +3 more sources

Carborane-Containing Iron Oxide@Gold Nanoparticles for Potential Application in Neutron Capture Therapy [PDF]

open access: yesNanomaterials
Cancer remains one of the most pressing global health challenges, driving the need for innovative treatment strategies. Boron neutron capture therapy (BNCT) offers a highly selective approach to destroying cancer cells while sparing healthy tissues.
Zhangali A. Bekbol   +8 more
doaj   +2 more sources

Structure-Activity Relationships of closo- and nido-Carborane Erlotinib Analogs: Lipophilicity as a Key Modulator of Anti-Glioma Activity [PDF]

open access: yesPharmaceuticals
Background/Objectives: To enhance the anti-glioma activity of erlotinib, we previously developed a series of carborane-based analogs exploiting the concept of three-dimensional bioisosterism.
Belén Dávila   +8 more
doaj   +2 more sources

Carboranes as unique pharmacophores in antitumor medicinal chemistry

open access: yesMolecular Therapy: Oncolytics, 2022
Carborane is a carbon-boron molecular cluster that can be viewed as a 3D analog of benzene. It features special physical and chemical properties, and thus has the potential to serve as a new type of pharmacophore for drug design and discovery.
Yu Chen   +10 more
doaj   +1 more source

Synthesis, Crystal Structure, and Some Transformations of 9,12-Dichloro-ortho-Carborane

open access: yesCrystals, 2022
Reaction of ortho-carborane with anhydrous AlCl3 in chloroform results in a mixture of 9-chloro, 9,12-dichloro, and 8,9,12-trichloro derivatives with 9,12-dichloro-ortho-carborane being the main product. Molecular crystal structure of 9,12-dichloro-ortho-
Sergey A. Anufriev   +4 more
doaj   +1 more source

Exploiting Blood Transport Proteins as Carborane Supramolecular Vehicles for Boron Neutron Capture Therapy

open access: yesNanomaterials, 2023
Carboranes are promising agents for applications in boron neutron capture therapy (BNCT), but their hydrophobicity prevents their use in physiological environments.
Tainah Dorina Marforio   +3 more
doaj   +1 more source

Conformation-Dependent Electron Donation of Nido-Carborane Substituents and Its Influence on Phosphorescence of Tris(2,2′-bipyridyl)ruthenium(II) Complex

open access: yesCrystals, 2022
In this work, we report the synthesis of the nido-carborane-substituted ruthenium complexes and the substituent effects of nido-carboranes on the optical properties.
Kyoya Uemura   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy